
A leading provider of
innovative DNA Screening solutions
This is the most common rearrangement in AML and MDS and involves the deletion of a region of 5q including EGR1. This is thought to be a good candidate gene for these patients because, with interaction between it and the fibronectin, TGFB1 and plasminogen activator 1 genes it can inhibit cancer growth.
Cat. No. LPH 024-S (5 tests)
Cat. No. LPH 024 (10 tests)
These products are only available labelled as Analyte Specific Reagents (ASR) in the USA.
Developed &